Clinical Trials for John Murray

19 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
Basic ScienceMMCTISS0901-M
03/01/2009
Head and Neck Tumor tissue Repository
OtherVICC090513-M
01/25/2012
Arthralgia in women with early stage breast cancer taking aromatase inhibitors: the Breast Cancer Adjuvant Therapy (BCAT) longitudinal cohort/registry study
OtherMDASUPP0914-M
02/11/2011
A multi-center Study in Patients Undergoing Anthracycline-Based Chemotherapy to Assess the Effectivenessof Using Biomarkers to detect and Identify Cardiotoxicity and Describe Treatment
OtherECOGBREE2Z04-M
06/11/2008
Quality of LIfe in Younger Breast Cancer Survivors
OtherCTSUBREC70301-M
06/11/2007
Quality of Life, Employment and Informal Care Cost Analysis in Women Receiving Adjuvant Chemotherapy for Breast Cancer with 0-3 Positive Axillary Lymph Nodes
Supportive CareALLIANCEA221102-M
11/06/2012
Randomized study of subQ testosterone in the adjuvant treatment of postmenopausal women with aromatase inhibitor induced arthralgias
TreatmentCTSUBRENB-43-M
04/26/2012
A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy
TreatmentCTSUNSABPBREB-47-M
04/26/2012
A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women with Node-Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer 
TreatmentCTSUBRENCCTGMA32-M
04/23/2012
A Phase III Randomized Trial of Metformin versus Placebo on Recurrence and Survival in Early Stage Breast Cancer
TreatmentCTSUBRES1007-M
05/25/2011
Phase III randomized trial of standard adjuvant endocrine therapy +/- chemo in patients with 1-3 positive nodes, hormone receptor positive and Her2 negative breast cancer with recurrence score (RS) of 25 or less
TreatmentCTSUGI80702-M
05/05/2011
A Phase III Trial of 6 versus 12 Treatments of Adjuvant FOLFOX plus Celecoxib or placebo for patients with Resected Stage III Colon Cancer
TreatmentECOGTHO5508-M
02/09/2011
Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC
TreatmentCTSUGIC80802-M
12/07/2010
Phase III randomized study of sorafenib (IND 69896, NSC 724772) plus doxorubicin versus sorafenib in patients with advanced hepatocellular carcinoma (HCC)
TreatmentCTSUBREC40603-M
12/07/2010
Randomized Phase II 2 X 2 Factorial Trial Of The Addition Of Carboplatin +/- Bevacizumab To Neoadjuvant Weekly Paclitaxel Followed By Dose-Dense AC In Hormone Receptor-Poor/HER2-Negative Resectable Breast Cancer
TreatmentECOGTHO4508-M
12/07/2010
Three-Arm Randomized Phase II Study of Carboplatin and Paclitaxel in Combination with Cetuximab, IMC-A12 or Both for Advanced Non-small Cell Lung Cancer Patients WhoWill Not Receive Bevacizumab-based Therapy
TreatmentCTSUTHOC30607-M
02/17/2010
ARandomized, Phase III, Double-Blind Placebo-Controlled Trial of Sunitinib as Maintenance Therapy in Non-Progressing Patients following an Initial Four Cycles of Platinum-Based Combination Chemotherapy in Advanced, Stage IIIB/IV Non-Small Cell Lung Cancer
TreatmentECOGHNE1305-M
02/11/2009
A Phase III Randomized Trial of Chemotherapy with or without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer
TreatmentCTSUUROC90203-M
11/05/2007
A randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Prostatectomy Versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer
TreatmentECOGTHOE1505-M
07/27/2007
A Phase III Randomized Trial of Adjuvant Chemotherapy with or without Bevacizumab for Patients with Completely Resected Stage IB (> or = 4 cm)- IIIA Non-Small Cell Lung Cancer (NSCLC)

Back to Find By Doctor

You do not have JavaScript enabled. This site works better with JavaScript turned on.